Asia-Pacific Infectious Disease Market Outlook to 2025

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: March 30, 2020 Report Code: GDMECR1322DB-ST

Select Item

GlobalData’s “Asia – Pacific Infectious Disease Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Asia – Pacific Infectious Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Chlamydia Trachomatis Tests, Clostridium difficile Tests, Cytomegalovirus (CMV) Tests, Hepatitis Tests, Human Immunodeficiency Virus (HIV) Tests, Human Papilloma Virus (HPV) Tests, Human T-Lymphotropic Virus (HTLV) Tests, Multi-parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs, Multi-parameter HIV, Hepatitis B, and Hepatitis C Nucleic Acid Amplification Tests (NAATs), Mycobacterium Tuberculosis Tests, Neisseria Gonorrhoeae Tests and Treponema pallidum Tests.

The Asia – Pacific Infectious Disease Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for Infectious Disease Market.
• Global corporate-level profiles of key companies operating within the Asia – Pacific Infectious Disease Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Asia – Pacific Infectious Disease Tests is segmented as follows:

• Chlamydia Trachomatis Tests

• Clostridium difficile Tests

• Cytomegalovirus (CMV) Tests

• Hepatitis Tests

• Human Immunodeficiency Virus (HIV) Tests

• Human Papilloma Virus (HPV) Tests

• Human T-Lymphotropic Virus (HTLV) Tests

• Multi-parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs

• Multi-parameter HIV, Hepatitis B, and Hepatitis C Nucleic Acid Amplification Tests (NAATs)

• Mycobacterium Tuberculosis Tests

• Neisseria Gonorrhoeae Tests

• Treponema pallidum Tests

Reasons to Buy

Key Reasons to Purchase – The Asia – Pacific Infectious Disease Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “Asia - Pacific Infectious Disease Market Outlook to 2025” report:
• F. Hoffmann-La Roche Ltd
• Abbott Laboratories
• Siemens Healthineers AG

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 11

2 Introduction 15

2.1 What Is This Report About? 15

2.2 Infectious Disease Market Segmentation 15

2.3 Definitions of Markets Covered in the Report 17

3 Infectious Disease Market, Asia-Pacific 24

3.1 Infectious Disease Market, Asia-Pacific, Revenue ($m), 2015-2025 24

3.2 Infectious Disease Market, Asia-Pacific, Revenue ($m), 2015-2025 26

3.3 Infectious Disease Market, Asia-Pacific, Volume (Units), 2015-2025 31

3.4 Infectious Disease Market, Asia-Pacific, Volume (Units), 2015-2025 33

3.5 Infectious Disease Market, Asia-Pacific, Company Share by Revenue ($m), 2018 38

4 Infectious Disease Market, Australia 40

4.1 Infectious Disease Market, Australia, Revenue ($m), 2015-2025 40

4.1.1 Chlamydia Trachomatis Tests Market, Australia, Revenue ($m), by Segment, 2015-2025 45

4.1.2 Clostridium difficile Tests Market, Australia, Revenue ($m), by Segment, 2015-2025 47

4.1.3 Cytomegalovirus (CMV) Tests Market, Australia, Revenue ($m), by Segment, 2015-2025 49

4.1.4 Hepatitis Tests Market, Australia, Revenue ($m), by Segment, 2015-2025 51

4.1.5 Human Immunodeficiency Virus (HIV) Tests Market, Australia, Revenue ($m), by Segment, 2015-2025 53

4.1.6 Human Papilloma Virus (HPV) Tests Market, Australia, Revenue ($m), by Segment, 2015-2025 56

4.1.7 Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Revenue ($m), by Segment, 2015-2025 58

4.1.8 Mycobacterium Tuberculosis Tests Market, Australia, Revenue ($m), by Segment, 2015-2025 60

4.1.9 Neisseria Gonorrhoeae Tests Market, Australia, Revenue ($m), by Segment, 2015-2025 62

4.1.10 Treponema pallidum Tests Market, Australia, Revenue ($m), by Segment, 2015-2025 64

4.2 Infectious Disease Market, Australia, Volume (Units), 2015-2025 67

4.2.1 Chlamydia Trachomatis Tests Market, Australia, Volume (Units), by Segment, 2015-2025 72

4.2.2 Clostridium difficile Tests Market, Australia, Volume (Units), by Segment, 2015-2025 74

4.2.3 Cytomegalovirus (CMV) Tests Market, Australia, Volume (Units), by Segment, 2015-2025 77

4.2.4 Hepatitis Tests Market, Australia, Volume (Units), by Segment, 2015-2025 79

4.2.5 Human Immunodeficiency Virus (HIV) Tests Market, Australia, Volume (Units), by Segment, 2015-2025 81

4.2.6 Human Papilloma Virus (HPV) Tests Market, Australia, Volume (Units), by Segment, 2015-2025 84

4.2.7 Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Volume (Units), by Segment, 2015-2025 86

4.2.8 Mycobacterium Tuberculosis Tests Market, Australia, Volume (Units), by Segment, 2015-2025 88

4.2.9 Neisseria Gonorrhoeae Tests Market, Australia, Volume (Units), by Segment, 2015-2025 90

4.2.10 Treponema pallidum Tests Market, Australia, Volume (Units), by Segment, 2015-2025 92

4.3 Infectious Disease Market, Australia, Average Price ($), 2015-2025 95

4.4 Infectious Disease Market, Australia, Distribution Share by Revenue ($m), 2018 101

4.5 Infectious Disease Market, Australia, Company Share by Revenue ($m), 2018 102

5 Infectious Disease Market, China 104

5.1 Infectious Disease Market, China, Revenue ($m), 2015-2025 104

5.1.1 Chlamydia Trachomatis Tests Market, China, Revenue ($m), by Segment, 2015-2025 107

5.1.2 Clostridium difficile Tests Market, China, Revenue ($m), by Segment, 2015-2025 109

5.1.3 Cytomegalovirus (CMV) Tests Market, China, Revenue ($m), by Segment, 2015-2025 111

5.1.4 Hepatitis Tests Market, China, Revenue ($m), by Segment, 2015-2025 113

5.1.5 Human Immunodeficiency Virus (HIV) Tests Market, China, Revenue ($m), by Segment, 2015-2025 115

5.1.6 Human Papilloma Virus (HPV) Tests Market, China, Revenue ($m), by Segment, 2015-2025 117

5.1.7 Human T-Lymphotropic Virus (HTLV) Tests Market, China, Revenue ($m), by Segment, 2015-2025 119

5.1.8 Mycobacterium Tuberculosis Tests Market, China, Revenue ($m), by Segment, 2015-2025 121

5.1.9 Neisseria Gonorrhoeae Tests Market, China, Revenue ($m), by Segment, 2015-2025 123

5.1.10 Treponema pallidum Tests Market, China, Revenue ($m), by Segment, 2015-2025 125

5.2 Infectious Disease Market, China, Volume (Units), 2015-2025 128

5.2.1 Chlamydia Trachomatis Tests Market, China, Volume (Units), by Segment, 2015-2025 133

5.2.2 Clostridium difficile Tests Market, China, Volume (Units), by Segment, 2015-2025 135

5.2.3 Cytomegalovirus (CMV) Tests Market, China, Volume (Units), by Segment, 2015-2025 138

5.2.4 Hepatitis Tests Market, China, Volume (Units), by Segment, 2015-2025 140

5.2.5 Human Immunodeficiency Virus (HIV) Tests Market, China, Volume (Units), by Segment, 2015-2025 142

5.2.6 Human Papilloma Virus (HPV) Tests Market, China, Volume (Units), by Segment, 2015-2025 145

5.2.7 Human T-Lymphotropic Virus (HTLV) Tests Market, China, Volume (Units), by Segment, 2015-2025 147

5.2.8 Mycobacterium Tuberculosis Tests Market, China, Volume (Units), by Segment, 2015-2025 149

5.2.9 Neisseria Gonorrhoeae Tests Market, China, Volume (Units), by Segment, 2015-2025 151

5.2.10 Treponema pallidum Tests Market, China, Volume (Units), by Segment, 2015-2025 153

5.3 Infectious Disease Market, China, Average Price ($), 2015-2025 156

5.4 Infectious Disease Market, China, Distribution Share by Revenue ($m), 2018 162

5.5 Infectious Disease Market, China, Company Share by Revenue ($m), 2018 163

6 Infectious Disease Market, India 165

6.1 Infectious Disease Market, India, Revenue ($m), 2015-2025 165

6.1.1 Chlamydia Trachomatis Tests Market, India, Revenue ($m), by Segment, 2015-2025 168

6.1.2 Clostridium difficile Tests Market, India, Revenue ($m), by Segment, 2015-2025 170

6.1.3 Cytomegalovirus (CMV) Tests Market, India, Revenue ($m), by Segment, 2015-2025 172

6.1.4 Hepatitis Tests Market, India, Revenue ($m), by Segment, 2015-2025 174

6.1.5 Human Immunodeficiency Virus (HIV) Tests Market, India, Revenue ($m), by Segment, 2015-2025 176

6.1.6 Human Papilloma Virus (HPV) Tests Market, India, Revenue ($m), by Segment, 2015-2025 178

6.1.7 Human T-Lymphotropic Virus (HTLV) Tests Market, India, Revenue ($m), by Segment, 2015-2025 180

6.1.8 Mycobacterium Tuberculosis Tests Market, India, Revenue ($m), by Segment, 2015-2025 182

6.1.9 Neisseria Gonorrhoeae Tests Market, India, Revenue ($m), by Segment, 2015-2025 184

6.1.10 Treponema pallidum Tests Market, India, Revenue ($m), by Segment, 2015-2025 186

6.2 Infectious Disease Market, India, Volume (Units), 2015-2025 189

6.2.1 Chlamydia Trachomatis Tests Market, India, Volume (Units), by Segment, 2015-2025 194

6.2.2 Clostridium difficile Tests Market, India, Volume (Units), by Segment, 2015-2025 196

6.2.3 Cytomegalovirus (CMV) Tests Market, India, Volume (Units), by Segment, 2015-2025 199

6.2.4 Hepatitis Tests Market, India, Volume (Units), by Segment, 2015-2025 201

6.2.5 Human Immunodeficiency Virus (HIV) Tests Market, India, Volume (Units), by Segment, 2015-2025 203

6.2.6 Human Papilloma Virus (HPV) Tests Market, India, Volume (Units), by Segment, 2015-2025 206

6.2.7 Human T-Lymphotropic Virus (HTLV) Tests Market, India, Volume (Units), by Segment, 2015-2025 208

6.2.8 Mycobacterium Tuberculosis Tests Market, India, Volume (Units), by Segment, 2015-2025 210

6.2.9 Neisseria Gonorrhoeae Tests Market, India, Volume (Units), by Segment, 2015-2025 212

6.2.10 Treponema pallidum Tests Market, India, Volume (Units), by Segment, 2015-2025 214

6.3 Infectious Disease Market, India, Average Price ($), 2015-2025 217

6.4 Infectious Disease Market, India, Distribution Share by Revenue ($m), 2018 223

6.5 Infectious Disease Market, India, Company Share by Revenue ($m), 2018 224

7 Infectious Disease Market, Japan 226

7.1 Infectious Disease Market, Japan, Revenue ($m), 2015-2025 226

7.1.1 Chlamydia Trachomatis Tests Market, Japan, Revenue ($m), by Segment, 2015-2025 229

7.1.2 Clostridium difficile Tests Market, Japan, Revenue ($m), by Segment, 2015-2025 231

7.1.3 Cytomegalovirus (CMV) Tests Market, Japan, Revenue ($m), by Segment, 2015-2025 234

7.1.4 Hepatitis Tests Market, Japan, Revenue ($m), by Segment, 2015-2025 236

7.1.5 Human Immunodeficiency Virus (HIV) Tests Market, Japan, Revenue ($m), by Segment, 2015-2025 238

7.1.6 Human Papilloma Virus (HPV) Tests Market, Japan, Revenue ($m), by Segment, 2015-2025 241

7.1.7 Human T-Lymphotropic Virus (HTLV) Tests Market, Japan, Revenue ($m), by Segment, 2015-2025 243

7.1.8 Mycobacterium Tuberculosis Tests Market, Japan, Revenue ($m), by Segment, 2015-2025 245

7.1.9 Neisseria Gonorrhoeae Tests Market, Japan, Revenue ($m), by Segment, 2015-2025 247

7.1.10 Treponema pallidum Tests Market, Japan, Revenue ($m), by Segment, 2015-2025 249

7.2 Infectious Disease Market, Japan, Volume (Units), 2015-2025 252

7.2.1 Chlamydia Trachomatis Tests Market, Japan, Volume (Units), by Segment, 2015-2025 257

7.2.2 Clostridium difficile Tests Market, Japan, Volume (Units), by Segment, 2015-2025 259

7.2.3 Cytomegalovirus (CMV) Tests Market, Japan, Volume (Units), by Segment, 2015-2025 262

7.2.4 Hepatitis Tests Market, Japan, Volume (Units), by Segment, 2015-2025 264

7.2.5 Human Immunodeficiency Virus (HIV) Tests Market, Japan, Volume (Units), by Segment, 2015-2025 266

7.2.6 Human Papilloma Virus (HPV) Tests Market, Japan, Volume (Units), by Segment, 2015-2025 269

7.2.7 Human T-Lymphotropic Virus (HTLV) Tests Market, Japan, Volume (Units), by Segment, 2015-2025 271

7.2.8 Mycobacterium Tuberculosis Tests Market, Japan, Volume (Units), by Segment, 2015-2025 273

7.2.9 Neisseria Gonorrhoeae Tests Market, Japan, Volume (Units), by Segment, 2015-2025 275

7.2.10 Treponema pallidum Tests Market, Japan, Volume (Units), by Segment, 2015-2025 277

7.3 Infectious Disease Market, Japan, Average Price ($), 2015-2025 280

7.4 Infectious Disease Market, Japan, Distribution Share by Revenue ($m), 2018 286

7.5 Infectious Disease Market, Japan, Company Share by Revenue ($m), 2018 287

8 Infectious Disease Market, South Korea 289

8.1 Infectious Disease Market, South Korea, Revenue ($m), 2015-2025 289

8.1.1 Chlamydia Trachomatis Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 292

8.1.2 Clostridium difficile Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 294

8.1.3 Cytomegalovirus (CMV) Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 297

8.1.4 Hepatitis Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 299

8.1.5 Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 301

8.1.6 Human Papilloma Virus (HPV) Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 304

8.1.7 Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 306

8.1.8 Mycobacterium Tuberculosis Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 308

8.1.9 Neisseria Gonorrhoeae Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 310

8.1.10 Treponema pallidum Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 312

8.2 Infectious Disease Market, South Korea, Volume (Units), 2015-2025 315

8.2.1 Chlamydia Trachomatis Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 320

8.2.2 Clostridium difficile Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 322

8.2.3 Cytomegalovirus (CMV) Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 325

8.2.4 Hepatitis Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 327

8.2.5 Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 329

8.2.6 Human Papilloma Virus (HPV) Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 332

8.2.7 Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 334

8.2.8 Mycobacterium Tuberculosis Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 336

8.2.9 Neisseria Gonorrhoeae Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 338

8.2.10 Treponema pallidum Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 340

8.3 Infectious Disease Market, South Korea, Average Price ($), 2015-2025 343

8.4 Infectious Disease Market, South Korea, Distribution Share by Revenue ($m), 2018 349

8.5 Infectious Disease Market, South Korea, Company Share by Revenue ($m), 2018 350

9 Overview of Key Companies in Asia-Pacific Infectious Disease Market 352

9.1 F. Hoffmann-La Roche Ltd 352

9.1.1 Company Overview 352

9.2 Abbott Laboratories 352

9.2.1 Company Overview 352

9.3 Siemens Healthineers AG 352

9.3.1 Company Overview 352

9.4 Grifols SA 353

9.4.1 Company Overview 353

9.5 Hologic Inc 353

9.5.1 Company Overview 353

9.6 Qiagen NV 353

9.6.1 Company Overview 353

9.7 Miraca Holdings Inc 353

9.7.1 Company Overview 353

9.8 Danaher Corp 354

9.8.1 Company Overview 354

9.9 Bio-Rad Laboratories Inc 354

9.9.1 Company Overview 354

9.10 Oxford Immunotec Ltd 354

9.10.1 Company Overview 354

10 Infectious Disease Market Pipeline Products 355

11 Recent Developments 360

11.1 Corporate Communications 360

11.1.1 Oct 28, 2019: Genetic Signature: Non-Executive Director retirement 360

11.1.2 Oct 23, 2019: Shuwen Biotech designated as an International Cooperation Base for Medical Diagnostic Technologies 360

11.1.3 Aug 20, 2019: Genera Biosystems announces resignation of executive director and company secretary 360

11.1.4 Jul 29, 2019: Anteo Diagnostics: CEO appointment 361

11.1.5 Jul 22, 2019: Anteo Diagnostics: Management changes 361

11.1.6 Jul 11, 2019: Genera Biosystems: Appointment of Executive Director 362

11.1.7 Jul 02, 2019: Genera Biosystems: Resignation of non-executive director 362

11.1.8 May 27, 2019: Gordon Ballantyne, Managing Director and Chief Executive Officer to depart healthscope 363

11.1.9 May 09, 2019: Genera Biosystems: Resignation Of Non-execuitve Director 363

11.1.10 Apr 15, 2019: Anteo Diagnostics: Strengthens executive team with CEO appointment 363

11.1.11 Apr 12, 2019: Genera Biosystems: Key executive appointment & capital raising update 364

11.1.12 Mar 21, 2019: Oxford Immunotec announces Chief Financial Officer transition 365

11.1.13 Mar 04, 2019: Genetic Signatures: Change of Company Secretary 366

11.1.14 Feb 28, 2019: Anteo Diagnostics: Appointment of CFO and company secretary 366

11.2 Financial Announcements 366

11.2.1 Oct 16, 2019: Abbott reports third-quarter 2019 results 366

11.2.2 Aug 30, 2019: Fukuda orders 100 TetraGraph systems after regulatory approval 368

11.2.3 Jul 31, 2019: Genera Biosystems: Quarterly cash flow and business update 369

11.2.4 Jul 25, 2019: Genetic Signatures: Quarterly Activities Report – 30 June 2019 370

11.2.5 Jul 17, 2019: Abbott reports second-quarter 2019 results 371

11.2.6 May 01, 2019: Genera Biosystems: Appendix 4C quarterly cash flow and capital raising update 373

11.2.7 Apr 25, 2019: Biocartis Group Q1 2019 Business Update 374

11.2.8 Apr 24, 2019: Thermo Fisher Scientific announces first quarter 2019 results 376

11.2.9 Feb 28, 2019: Biocartis announces 2018 results and 2019 outlook 377

11.3 Government and Public Interest 381

11.3.1 May 14, 2019: Ortho Clinical Diagnostics to host 4th Annual Hospital C-Suite Summit in Singapore 381

11.4 Legal And Regulatory 382

11.4.1 Jul 16, 2019: Swiss agree to extradite Chinese researcher in US corporate espionage case 382

11.4.2 Apr 04, 2019: Theradiag and HOB Biotech settle their legal dispute 382

11.4.3 Mar 04, 2019: Genetic Signatures: Change of Registered Address 382

11.5 Other Significant Developments 383

11.5.1 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI 383

11.5.2 Oct 30, 2019: Anteo delivers a quarter of progressive strategy execution 384

11.5.3 Oct 28, 2019: Genetic Signatures: Quarterly activities report – 30 September 2019 384

11.5.4 Oct 28, 2019: Genetic Signatures: A$2.1m R&D rebate received 385

11.5.5 Oct 02, 2019: Double Bond Pharma signed a distribution agreement with Zoono 385

11.5.6 Aug 09, 2019: New diagnostic method for fungal infections could combat a major global health risk 386

11.5.7 Jul 01, 2019: Canon Medical Systems enters agreement with R-Pharm Holding for strategic partnership in the territory of the Russian Federation 387

11.5.8 Apr 29, 2019: Genetic Signatures: Quarterly activities report – 31 March 2019 387

11.5.9 Apr 08, 2019: UniSA startup releases AI app to detect Parkinson’s disease 388

11.5.10 Mar 19, 2019: Abbott introduces new digital service in India as part of its global a:care program 389

11.5.11 Feb 21, 2019: Anteo makes solid progress with GeneoDx partnership 390

11.6 Strategy And Business Planning 391

11.6.1 Nov 13, 2019: Thermo Fisher Scientific opens Customer Solution Center in China to support pharmaceutical and biopharmaceutical laboratories 391

11.6.2 Oct 14, 2019: Canon Medical to launch new division in Dubai, UAE 391

11.6.3 Jun 03, 2019: Mobidiag announces launch of Automobi Molecular Diagnostics 391

12 Appendix 393

12.1 Research Methodology 394

12.1.1 Coverage 394

12.1.2 Secondary Research 394

12.1.3 Primary Research 395

12.1.4 Market Modeling and Forecasting 396

12.1.5 Company Share Analysis 397

12.1.6 Distribution Share Analysis 398

12.1.7 Benchmarking 398

12.2 GlobalData Consulting 398

12.3 Contact Us 399

12.4 Disclaimer 399

Table

1.1 List of Tables

Table 1: Infectious Disease Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2015-2025 24

Table 2: Infectious Disease Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2015-2020 26

Table 3: Infectious Disease Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2021-2025 28

Table 4: Infectious Disease Market, Asia-Pacific, Volume (Units), 2015-2025 31

Table 5: Infectious Disease Market, Asia-Pacific, Volume (Units), 2015-2020 33

Table 6: Infectious Disease Market, Asia-Pacific, Volume (Units), 2021-2025 35

Table 7: Infectious Disease Market, Asia-Pacific, Company Share by Revenue ($m), USD Constant, 2018 38

Table 8: Infectious Disease Market, Australia, Revenue ($m), USD Constant, 2015-2020 40

Table 9: Infectious Disease Market, Australia, Revenue ($m), USD Constant, 2021-2025 42

Table 10: Chlamydia Trachomatis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 45

Table 11: Chlamydia Trachomatis Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 45

Table 12: Clostridium difficile Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 47

Table 13: Clostridium difficile Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 47

Table 14: Cytomegalovirus (CMV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 49

Table 15: Cytomegalovirus (CMV) Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 49

Table 16: Hepatitis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 51

Table 17: Hepatitis Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 51

Table 18: Human Immunodeficiency Virus (HIV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 53

Table 19: Human Immunodeficiency Virus (HIV) Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 54

Table 20: Human Papilloma Virus (HPV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 56

Table 21: Human Papilloma Virus (HPV) Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 56

Table 22: Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 58

Table 23: Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 58

Table 24: Mycobacterium Tuberculosis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 60

Table 25: Mycobacterium Tuberculosis Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 60

Table 26: Neisseria Gonorrhoeae Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 62

Table 27: Neisseria Gonorrhoeae Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 62

Table 28: Treponema pallidum Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 64

Table 29: Treponema pallidum Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 65

Table 30: Infectious Disease Market, Australia, Volume (Units), 2015-2020 67

Table 31: Infectious Disease Market, Australia, Volume (Units), 2021-2025 69

Table 32: Chlamydia Trachomatis Tests Market, Australia, Volume (Units), 2015-2020 72

Table 33: Chlamydia Trachomatis Tests Market, Australia, Volume (Units), 2021-2025 72

Table 34: Clostridium difficile Tests Market, Australia, Volume (Units), 2015-2020 74

Table 35: Clostridium difficile Tests Market, Australia, Volume (Units), 2021-2025 75

Table 36: Cytomegalovirus (CMV) Tests Market, Australia, Volume (Units), 2015-2020 77

Table 37: Cytomegalovirus (CMV) Tests Market, Australia, Volume (Units), 2021-2025 77

Table 38: Hepatitis Tests Market, Australia, Volume (Units), 2015-2020 79

Table 39: Hepatitis Tests Market, Australia, Volume (Units), 2021-2025 79

Table 40: Human Immunodeficiency Virus (HIV) Tests Market, Australia, Volume (Units), 2015-2020 81

Table 41: Human Immunodeficiency Virus (HIV) Tests Market, Australia, Volume (Units), 2021-2025 82

Table 42: Human Papilloma Virus (HPV) Tests Market, Australia, Volume (Units), 2015-2020 84

Table 43: Human Papilloma Virus (HPV) Tests Market, Australia, Volume (Units), 2021-2025 84

Table 44: Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Volume (Units), 2015-2020 86

Table 45: Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Volume (Units), 2021-2025 86

Table 46: Mycobacterium Tuberculosis Tests Market, Australia, Volume (Units), 2015-2020 88

Table 47: Mycobacterium Tuberculosis Tests Market, Australia, Volume (Units), 2021-2025 88

Table 48: Neisseria Gonorrhoeae Tests Market, Australia, Volume (Units), 2015-2020 90

Table 49: Neisseria Gonorrhoeae Tests Market, Australia, Volume (Units), 2021-2025 90

Table 50: Treponema pallidum Tests Market, Australia, Volume (Units), 2015-2020 92

Table 51: Treponema pallidum Tests Market, Australia, Volume (Units), 2021-2025 93

Table 52: Infectious Disease Market, Australia, Average Price ($), 2015-2020 94

Table 53: Infectious Disease Market, Australia, Average Price ($), 2021-2025 97

Table 54: Infectious Disease Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2018 100

Table 55: Infectious Disease Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 102

Table 56: Infectious Disease Market, China, Revenue ($m), USD Constant, 2015-2020 104

Table 57: Infectious Disease Market, China, Revenue ($m), USD Constant, 2021-2025 105

Table 58: Chlamydia Trachomatis Tests Market, China, Revenue ($m), USD Constant, 2015-2020 107

Table 59: Chlamydia Trachomatis Tests Market, China, Revenue ($m), USD Constant, 2021-2025 107

Table 60: Clostridium difficile Tests Market, China, Revenue ($m), USD Constant, 2015-2020 109

Table 61: Clostridium difficile Tests Market, China, Revenue ($m), USD Constant, 2021-2025 109

Table 62: Cytomegalovirus (CMV) Tests Market, China, Revenue ($m), USD Constant, 2015-2020 111

Table 63: Cytomegalovirus (CMV) Tests Market, China, Revenue ($m), USD Constant, 2021-2025 111

Table 64: Hepatitis Tests Market, China, Revenue ($m), USD Constant, 2015-2020 113

Table 65: Hepatitis Tests Market, China, Revenue ($m), USD Constant, 2021-2025 113

Table 66: Human Immunodeficiency Virus (HIV) Tests Market, China, Revenue ($m), USD Constant, 2015-2020 115

Table 67: Human Immunodeficiency Virus (HIV) Tests Market, China, Revenue ($m), USD Constant, 2021-2025 115

Table 68: Human Papilloma Virus (HPV) Tests Market, China, Revenue ($m), USD Constant, 2015-2020 117

Table 69: Human Papilloma Virus (HPV) Tests Market, China, Revenue ($m), USD Constant, 2021-2025 117

Table 70: Human T-Lymphotropic Virus (HTLV) Tests Market, China, Revenue ($m), USD Constant, 2015-2020 119

Table 71: Human T-Lymphotropic Virus (HTLV) Tests Market, China, Revenue ($m), USD Constant, 2021-2025 119

Table 72: Mycobacterium Tuberculosis Tests Market, China, Revenue ($m), USD Constant, 2015-2020 121

Table 73: Mycobacterium Tuberculosis Tests Market, China, Revenue ($m), USD Constant, 2021-2025 121

Table 74: Neisseria Gonorrhoeae Tests Market, China, Revenue ($m), USD Constant, 2015-2020 123

Table 75: Neisseria Gonorrhoeae Tests Market, China, Revenue ($m), USD Constant, 2021-2025 123

Table 76: Treponema pallidum Tests Market, China, Revenue ($m), USD Constant, 2015-2020 125

Table 77: Treponema pallidum Tests Market, China, Revenue ($m), USD Constant, 2021-2025 126

Table 78: Infectious Disease Market, China, Volume (Units), 2015-2020 128

Table 79: Infectious Disease Market, China, Volume (Units), 2021-2025 130

Table 80: Chlamydia Trachomatis Tests Market, China, Volume (Units), 2015-2020 133

Table 81: Chlamydia Trachomatis Tests Market, China, Volume (Units), 2021-2025 133

Table 82: Clostridium difficile Tests Market, China, Volume (Units), 2015-2020 135

Table 83: Clostridium difficile Tests Market, China, Volume (Units), 2021-2025 136

Table 84: Cytomegalovirus (CMV) Tests Market, China, Volume (Units), 2015-2020 138

Table 85: Cytomegalovirus (CMV) Tests Market, China, Volume (Units), 2021-2025 138

Table 86: Hepatitis Tests Market, China, Volume (Units), 2015-2020 140

Table 87: Hepatitis Tests Market, China, Volume (Units), 2021-2025 140

Table 88: Human Immunodeficiency Virus (HIV) Tests Market, China, Volume (Units), 2015-2020 142

Table 89: Human Immunodeficiency Virus (HIV) Tests Market, China, Volume (Units), 2021-2025 143

Table 90: Human Papilloma Virus (HPV) Tests Market, China, Volume (Units), 2015-2020 145

Table 91: Human Papilloma Virus (HPV) Tests Market, China, Volume (Units), 2021-2025 145

Table 92: Human T-Lymphotropic Virus (HTLV) Tests Market, China, Volume (Units), 2015-2020 147

Table 93: Human T-Lymphotropic Virus (HTLV) Tests Market, China, Volume (Units), 2021-2025 147

Table 94: Mycobacterium Tuberculosis Tests Market, China, Volume (Units), 2015-2020 149

Table 95: Mycobacterium Tuberculosis Tests Market, China, Volume (Units), 2021-2025 149

Table 96: Neisseria Gonorrhoeae Tests Market, China, Volume (Units), 2015-2020 151

Table 97: Neisseria Gonorrhoeae Tests Market, China, Volume (Units), 2021-2025 151

Table 98: Treponema pallidum Tests Market, China, Volume (Units), 2015-2020 153

Table 99: Treponema pallidum Tests Market, China, Volume (Units), 2021-2025 154

Table 100: Infectious Disease Market, China, Average Price ($), 2015-2020 155

Table 101: Infectious Disease Market, China, Average Price ($), 2021-2025 158

Table 102: Infectious Disease Market, China, Distribution Share by Revenue ($m), USD Constant, 2018 161

Table 103: Infectious Disease Market, China, Company Share by Revenue ($m), USD Constant, 2018 163

Table 104: Infectious Disease Market, India, Revenue ($m), USD Constant, 2015-2020 165

Table 105: Infectious Disease Market, India, Revenue ($m), USD Constant, 2021-2025 166

Table 106: Chlamydia Trachomatis Tests Market, India, Revenue ($m), USD Constant, 2015-2020 168

Table 107: Chlamydia Trachomatis Tests Market, India, Revenue ($m), USD Constant, 2021-2025 168

Table 108: Clostridium difficile Tests Market, India, Revenue ($m), USD Constant, 2015-2020 170

Table 109: Clostridium difficile Tests Market, India, Revenue ($m), USD Constant, 2021-2025 170

Table 110: Cytomegalovirus (CMV) Tests Market, India, Revenue ($m), USD Constant, 2015-2020 172

Table 111: Cytomegalovirus (CMV) Tests Market, India, Revenue ($m), USD Constant, 2021-2025 172

Table 112: Hepatitis Tests Market, India, Revenue ($m), USD Constant, 2015-2020 174

Table 113: Hepatitis Tests Market, India, Revenue ($m), USD Constant, 2021-2025 174

Table 114: Human Immunodeficiency Virus (HIV) Tests Market, India, Revenue ($m), USD Constant, 2015-2020 176

Table 115: Human Immunodeficiency Virus (HIV) Tests Market, India, Revenue ($m), USD Constant, 2021-2025 176

Table 116: Human Papilloma Virus (HPV) Tests Market, India, Revenue ($m), USD Constant, 2015-2020 178

Table 117: Human Papilloma Virus (HPV) Tests Market, India, Revenue ($m), USD Constant, 2021-2025 178

Table 118: Human T-Lymphotropic Virus (HTLV) Tests Market, India, Revenue ($m), USD Constant, 2015-2020 180

Table 119: Human T-Lymphotropic Virus (HTLV) Tests Market, India, Revenue ($m), USD Constant, 2021-2025 180

Table 120: Mycobacterium Tuberculosis Tests Market, India, Revenue ($m), USD Constant, 2015-2020 182

Table 121: Mycobacterium Tuberculosis Tests Market, India, Revenue ($m), USD Constant, 2021-2025 182

Table 122: Neisseria Gonorrhoeae Tests Market, India, Revenue ($m), USD Constant, 2015-2020 184

Table 123: Neisseria Gonorrhoeae Tests Market, India, Revenue ($m), USD Constant, 2021-2025 184

Table 124: Treponema pallidum Tests Market, India, Revenue ($m), USD Constant, 2015-2020 186

Table 125: Treponema pallidum Tests Market, India, Revenue ($m), USD Constant, 2021-2025 187

Table 126: Infectious Disease Market, India, Volume (Units), 2015-2020 189

Table 127: Infectious Disease Market, India, Volume (Units), 2021-2025 191

Table 128: Chlamydia Trachomatis Tests Market, India, Volume (Units), 2015-2020 194

Table 129: Chlamydia Trachomatis Tests Market, India, Volume (Units), 2021-2025 194

Table 130: Clostridium difficile Tests Market, India, Volume (Units), 2015-2020 196

Table 131: Clostridium difficile Tests Market, India, Volume (Units), 2021-2025 197

Table 132: Cytomegalovirus (CMV) Tests Market, India, Volume (Units), 2015-2020 199

Table 133: Cytomegalovirus (CMV) Tests Market, India, Volume (Units), 2021-2025 199

Table 134: Hepatitis Tests Market, India, Volume (Units), 2015-2020 201

Table 135: Hepatitis Tests Market, India, Volume (Units), 2021-2025 201

Table 136: Human Immunodeficiency Virus (HIV) Tests Market, India, Volume (Units), 2015-2020 203

Table 137: Human Immunodeficiency Virus (HIV) Tests Market, India, Volume (Units), 2021-2025 204

Table 138: Human Papilloma Virus (HPV) Tests Market, India, Volume (Units), 2015-2020 206

Table 139: Human Papilloma Virus (HPV) Tests Market, India, Volume (Units), 2021-2025 206

Table 140: Human T-Lymphotropic Virus (HTLV) Tests Market, India, Volume (Units), 2015-2020 208

Table 141: Human T-Lymphotropic Virus (HTLV) Tests Market, India, Volume (Units), 2021-2025 208

Table 142: Mycobacterium Tuberculosis Tests Market, India, Volume (Units), 2015-2020 210

Table 143: Mycobacterium Tuberculosis Tests Market, India, Volume (Units), 2021-2025 210

Table 144: Neisseria Gonorrhoeae Tests Market, India, Volume (Units), 2015-2020 212

Table 145: Neisseria Gonorrhoeae Tests Market, India, Volume (Units), 2021-2025 212

Table 146: Treponema pallidum Tests Market, India, Volume (Units), 2015-2020 214

Table 147: Treponema pallidum Tests Market, India, Volume (Units), 2021-2025 215

Table 148: Infectious Disease Market, India, Average Price ($), 2015-2020 216

Table 149: Infectious Disease Market, India, Average Price ($), 2021-2025 219

Table 150: Infectious Disease Market, India, Distribution Share by Revenue ($m), USD Constant, 2018 222

Table 151: Infectious Disease Market, India, Company Share by Revenue ($m), USD Constant, 2018 224

Table 152: Infectious Disease Market, Japan, Revenue ($m), USD Constant, 2015-2020 226

Table 153: Infectious Disease Market, Japan, Revenue ($m), USD Constant, 2021-2025 227

Table 154: Chlamydia Trachomatis Tests Market, Japan, Revenue ($m), USD Constant, 2015-2020 229

Table 155: Chlamydia Trachomatis Tests Market, Japan, Revenue ($m), USD Constant, 2021-2025 229

Table 156: Clostridium difficile Tests Market, Japan, Revenue ($m), USD Constant, 2015-2020 231

Table 157: Clostridium difficile Tests Market, Japan, Revenue ($m), USD Constant, 2021-2025 232

Table 158: Cytomegalovirus (CMV) Tests Market, Japan, Revenue ($m), USD Constant, 2015-2020 234

Table 159: Cytomegalovirus (CMV) Tests Market, Japan, Revenue ($m), USD Constant, 2021-2025 234

Table 160: Hepatitis Tests Market, Japan, Revenue ($m), USD Constant, 2015-2020 236

Table 161: Hepatitis Tests Market, Japan, Revenue ($m), USD Constant, 2021-2025 236

Table 162: Human Immunodeficiency Virus (HIV) Tests Market, Japan, Revenue ($m), USD Constant, 2015-2020 238

Table 163: Human Immunodeficiency Virus (HIV) Tests Market, Japan, Revenue ($m), USD Constant, 2021-2025 238

Table 164: Human Papilloma Virus (HPV) Tests Market, Japan, Revenue ($m), USD Constant, 2015-2020 241

Table 165: Human Papilloma Virus (HPV) Tests Market, Japan, Revenue ($m), USD Constant, 2021-2025 241

Table 166: Human T-Lymphotropic Virus (HTLV) Tests Market, Japan, Revenue ($m), USD Constant, 2015-2020 243

Table 167: Human T-Lymphotropic Virus (HTLV) Tests Market, Japan, Revenue ($m), USD Constant, 2021-2025 243

Table 168: Mycobacterium Tuberculosis Tests Market, Japan, Revenue ($m), USD Constant, 2015-2020 245

Table 169: Mycobacterium Tuberculosis Tests Market, Japan, Revenue ($m), USD Constant, 2021-2025 245

Table 170: Neisseria Gonorrhoeae Tests Market, Japan, Revenue ($m), USD Constant, 2015-2020 247

Table 171: Neisseria Gonorrhoeae Tests Market, Japan, Revenue ($m), USD Constant, 2021-2025 247

Table 172: Treponema pallidum Tests Market, Japan, Revenue ($m), USD Constant, 2015-2020 249

Table 173: Treponema pallidum Tests Market, Japan, Revenue ($m), USD Constant, 2021-2025 250

Table 174: Infectious Disease Market, Japan, Volume (Units), 2015-2020 252

Table 175: Infectious Disease Market, Japan, Volume (Units), 2021-2025 254

Table 176: Chlamydia Trachomatis Tests Market, Japan, Volume (Units), 2015-2020 257

Table 177: Chlamydia Trachomatis Tests Market, Japan, Volume (Units), 2021-2025 257

Table 178: Clostridium difficile Tests Market, Japan, Volume (Units), 2015-2020 259

Table 179: Clostridium difficile Tests Market, Japan, Volume (Units), 2021-2025 260

Table 180: Cytomegalovirus (CMV) Tests Market, Japan, Volume (Units), 2015-2020 262

Table 181: Cytomegalovirus (CMV) Tests Market, Japan, Volume (Units), 2021-2025 262

Table 182: Hepatitis Tests Market, Japan, Volume (Units), 2015-2020 264

Table 183: Hepatitis Tests Market, Japan, Volume (Units), 2021-2025 264

Table 184: Human Immunodeficiency Virus (HIV) Tests Market, Japan, Volume (Units), 2015-2020 266

Table 185: Human Immunodeficiency Virus (HIV) Tests Market, Japan, Volume (Units), 2021-2025 267

Table 186: Human Papilloma Virus (HPV) Tests Market, Japan, Volume (Units), 2015-2020 269

Table 187: Human Papilloma Virus (HPV) Tests Market, Japan, Volume (Units), 2021-2025 269

Table 188: Human T-Lymphotropic Virus (HTLV) Tests Market, Japan, Volume (Units), 2015-2020 271

Table 189: Human T-Lymphotropic Virus (HTLV) Tests Market, Japan, Volume (Units), 2021-2025 271

Table 190: Mycobacterium Tuberculosis Tests Market, Japan, Volume (Units), 2015-2020 273

Table 191: Mycobacterium Tuberculosis Tests Market, Japan, Volume (Units), 2021-2025 273

Table 192: Neisseria Gonorrhoeae Tests Market, Japan, Volume (Units), 2015-2020 275

Table 193: Neisseria Gonorrhoeae Tests Market, Japan, Volume (Units), 2021-2025 275

Table 194: Treponema pallidum Tests Market, Japan, Volume (Units), 2015-2020 277

Table 195: Treponema pallidum Tests Market, Japan, Volume (Units), 2021-2025 278

Table 196: Infectious Disease Market, Japan, Average Price ($), 2015-2020 279

Table 197: Infectious Disease Market, Japan, Average Price ($), 2021-2025 282

Table 198: Infectious Disease Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2018 285

Table 199: Infectious Disease Market, Japan, Company Share by Revenue ($m), USD Constant, 2018 287

Table 200: Infectious Disease Market, South Korea, Revenue ($m), USD Constant, 2015-2020 289

Table 201: Infectious Disease Market, South Korea, Revenue ($m), USD Constant, 2021-2025 290

Table 202: Chlamydia Trachomatis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 292

Table 203: Chlamydia Trachomatis Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 292

Table 204: Clostridium difficile Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 294

Table 205: Clostridium difficile Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 295

Table 206: Cytomegalovirus (CMV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 297

Table 207: Cytomegalovirus (CMV) Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 297

Table 208: Hepatitis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 299

Table 209: Hepatitis Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 299

Table 210: Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 301

Table 211: Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 302

Table 212: Human Papilloma Virus (HPV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 304

Table 213: Human Papilloma Virus (HPV) Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 304

Table 214: Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 306

Table 215: Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 306

Table 216: Mycobacterium Tuberculosis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 308

Table 217: Mycobacterium Tuberculosis Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 308

Table 218: Neisseria Gonorrhoeae Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 310

Table 219: Neisseria Gonorrhoeae Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 310

Table 220: Treponema pallidum Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 312

Table 221: Treponema pallidum Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 313

Table 222: Infectious Disease Market, South Korea, Volume (Units), 2015-2020 315

Table 223: Infectious Disease Market, South Korea, Volume (Units), 2021-2025 317

Table 224: Chlamydia Trachomatis Tests Market, South Korea, Volume (Units), 2015-2020 320

Table 225: Chlamydia Trachomatis Tests Market, South Korea, Volume (Units), 2021-2025 320

Table 226: Clostridium difficile Tests Market, South Korea, Volume (Units), 2015-2020 322

Table 227: Clostridium difficile Tests Market, South Korea, Volume (Units), 2021-2025 323

Table 228: Cytomegalovirus (CMV) Tests Market, South Korea, Volume (Units), 2015-2020 325

Table 229: Cytomegalovirus (CMV) Tests Market, South Korea, Volume (Units), 2021-2025 325

Table 230: Hepatitis Tests Market, South Korea, Volume (Units), 2015-2020 327

Table 231: Hepatitis Tests Market, South Korea, Volume (Units), 2021-2025 327

Table 232: Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Volume (Units), 2015-2020 329

Table 233: Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Volume (Units), 2021-2025 330

Table 234: Human Papilloma Virus (HPV) Tests Market, South Korea, Volume (Units), 2015-2020 332

Table 235: Human Papilloma Virus (HPV) Tests Market, South Korea, Volume (Units), 2021-2025 332

Table 236: Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Volume (Units), 2015-2020 334

Table 237: Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Volume (Units), 2021-2025 334

Table 238: Mycobacterium Tuberculosis Tests Market, South Korea, Volume (Units), 2015-2020 336

Table 239: Mycobacterium Tuberculosis Tests Market, South Korea, Volume (Units), 2021-2025 336

Table 240: Neisseria Gonorrhoeae Tests Market, South Korea, Volume (Units), 2015-2020 338

Table 241: Neisseria Gonorrhoeae Tests Market, South Korea, Volume (Units), 2021-2025 338

Table 242: Treponema pallidum Tests Market, South Korea, Volume (Units), 2015-2020 340

Table 243: Treponema pallidum Tests Market, South Korea, Volume (Units), 2021-2025 341

Table 244: Infectious Disease Market, South Korea, Average Price ($), 2015-2020 342

Table 245: Infectious Disease Market, South Korea, Average Price ($), 2021-2025 345

Table 246: Infectious Disease Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2018 348

Table 247: Infectious Disease Market, South Korea, Company Share by Revenue ($m), USD Constant, 2018 350

Table 248: Infectious Disease Market Pipeline Products 354

Table 249: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 395

Figures

1.2 List of Figures

Figure 1: Infectious Disease Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2015-2025 23

Figure 2: Infectious Disease Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2015-2025 25

Figure 3: Infectious Disease Market, Asia-Pacific, Volume (Units), 2015-2025 30

Figure 4: Infectious Disease Market, Asia-Pacific, Volume (Units), 2015-2025 32

Figure 5: Infectious Disease Market, Asia-Pacific, Company Share (%) 2018 37

Figure 6: Infectious Disease Market, Australia, Revenue ($m), USD Constant, 2015-2025 39

Figure 7: Chlamydia Trachomatis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 44

Figure 8: Clostridium difficile Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 46

Figure 9: Cytomegalovirus (CMV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 48

Figure 10: Hepatitis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 50

Figure 11: Human Immunodeficiency Virus (HIV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 52

Figure 12: Human Papilloma Virus (HPV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 55

Figure 13: Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 57

Figure 14: Mycobacterium Tuberculosis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 59

Figure 15: Neisseria Gonorrhoeae Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 61

Figure 16: Treponema pallidum Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 63

Figure 17: Infectious Disease Market, Australia, Volume (Units), 2015-2025 66

Figure 18: Chlamydia Trachomatis Tests Market, Australia, Volume (Units), 2015-2025 71

Figure 19: Clostridium difficile Tests Market, Australia, Volume (Units), 2015-2025 73

Figure 20: Cytomegalovirus (CMV) Tests Market, Australia, Volume (Units), 2015-2025 76

Figure 21: Hepatitis Tests Market, Australia, Volume (Units), 2015-2025 78

Figure 22: Human Immunodeficiency Virus (HIV) Tests Market, Australia, Volume (Units), 2015-2025 80

Figure 23: Human Papilloma Virus (HPV) Tests Market, Australia, Volume (Units), 2015-2025 83

Figure 24: Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Volume (Units), 2015-2025 85

Figure 25: Mycobacterium Tuberculosis Tests Market, Australia, Volume (Units), 2015-2025 87

Figure 26: Neisseria Gonorrhoeae Tests Market, Australia, Volume (Units), 2015-2025 89

Figure 27: Treponema pallidum Tests Market, Australia, Volume (Units), 2015-2025 91

Figure 28: Infectious Disease Market, Australia, Company Share (%) 2018 101

Figure 29: Infectious Disease Market, China, Revenue ($m), USD Constant, 2015-2025 103

Figure 30: Chlamydia Trachomatis Tests Market, China, Revenue ($m), USD Constant, 2015-2025 106

Figure 31: Clostridium difficile Tests Market, China, Revenue ($m), USD Constant, 2015-2025 108

Figure 32: Cytomegalovirus (CMV) Tests Market, China, Revenue ($m), USD Constant, 2015-2025 110

Figure 33: Hepatitis Tests Market, China, Revenue ($m), USD Constant, 2015-2025 112

Figure 34: Human Immunodeficiency Virus (HIV) Tests Market, China, Revenue ($m), USD Constant, 2015-2025 114

Figure 35: Human Papilloma Virus (HPV) Tests Market, China, Revenue ($m), USD Constant, 2015-2025 116

Figure 36: Human T-Lymphotropic Virus (HTLV) Tests Market, China, Revenue ($m), USD Constant, 2015-2025 118

Figure 37: Mycobacterium Tuberculosis Tests Market, China, Revenue ($m), USD Constant, 2015-2025 120

Figure 38: Neisseria Gonorrhoeae Tests Market, China, Revenue ($m), USD Constant, 2015-2025 122

Figure 39: Treponema pallidum Tests Market, China, Revenue ($m), USD Constant, 2015-2025 124

Figure 40: Infectious Disease Market, China, Volume (Units), 2015-2025 127

Figure 41: Chlamydia Trachomatis Tests Market, China, Volume (Units), 2015-2025 132

Figure 42: Clostridium difficile Tests Market, China, Volume (Units), 2015-2025 134

Figure 43: Cytomegalovirus (CMV) Tests Market, China, Volume (Units), 2015-2025 137

Figure 44: Hepatitis Tests Market, China, Volume (Units), 2015-2025 139

Figure 45: Human Immunodeficiency Virus (HIV) Tests Market, China, Volume (Units), 2015-2025 141

Figure 46: Human Papilloma Virus (HPV) Tests Market, China, Volume (Units), 2015-2025 144

Figure 47: Human T-Lymphotropic Virus (HTLV) Tests Market, China, Volume (Units), 2015-2025 146

Figure 48: Mycobacterium Tuberculosis Tests Market, China, Volume (Units), 2015-2025 148

Figure 49: Neisseria Gonorrhoeae Tests Market, China, Volume (Units), 2015-2025 150

Figure 50: Treponema pallidum Tests Market, China, Volume (Units), 2015-2025 152

Figure 51: Infectious Disease Market, China, Company Share (%) 2018 162

Figure 52: Infectious Disease Market, India, Revenue ($m), USD Constant, 2015-2025 164

Figure 53: Chlamydia Trachomatis Tests Market, India, Revenue ($m), USD Constant, 2015-2025 167

Figure 54: Clostridium difficile Tests Market, India, Revenue ($m), USD Constant, 2015-2025 169

Figure 55: Cytomegalovirus (CMV) Tests Market, India, Revenue ($m), USD Constant, 2015-2025 171

Figure 56: Hepatitis Tests Market, India, Revenue ($m), USD Constant, 2015-2025 173

Figure 57: Human Immunodeficiency Virus (HIV) Tests Market, India, Revenue ($m), USD Constant, 2015-2025 175

Figure 58: Human Papilloma Virus (HPV) Tests Market, India, Revenue ($m), USD Constant, 2015-2025 177

Figure 59: Human T-Lymphotropic Virus (HTLV) Tests Market, India, Revenue ($m), USD Constant, 2015-2025 179

Figure 60: Mycobacterium Tuberculosis Tests Market, India, Revenue ($m), USD Constant, 2015-2025 181

Figure 61: Neisseria Gonorrhoeae Tests Market, India, Revenue ($m), USD Constant, 2015-2025 183

Figure 62: Treponema pallidum Tests Market, India, Revenue ($m), USD Constant, 2015-2025 185

Figure 63: Infectious Disease Market, India, Volume (Units), 2015-2025 188

Figure 64: Chlamydia Trachomatis Tests Market, India, Volume (Units), 2015-2025 193

Figure 65: Clostridium difficile Tests Market, India, Volume (Units), 2015-2025 195

Figure 66: Cytomegalovirus (CMV) Tests Market, India, Volume (Units), 2015-2025 198

Figure 67: Hepatitis Tests Market, India, Volume (Units), 2015-2025 200

Figure 68: Human Immunodeficiency Virus (HIV) Tests Market, India, Volume (Units), 2015-2025 202

Figure 69: Human Papilloma Virus (HPV) Tests Market, India, Volume (Units), 2015-2025 205

Figure 70: Human T-Lymphotropic Virus (HTLV) Tests Market, India, Volume (Units), 2015-2025 207

Figure 71: Mycobacterium Tuberculosis Tests Market, India, Volume (Units), 2015-2025 209

Figure 72: Neisseria Gonorrhoeae Tests Market, India, Volume (Units), 2015-2025 211

Figure 73: Treponema pallidum Tests Market, India, Volume (Units), 2015-2025 213

Figure 74: Infectious Disease Market, India, Company Share (%) 2018 223

Figure 75: Infectious Disease Market, Japan, Revenue ($m), USD Constant, 2015-2025 225

Figure 76: Chlamydia Trachomatis Tests Market, Japan, Revenue ($m), USD Constant, 2015-2025 228

Figure 77: Clostridium difficile Tests Market, Japan, Revenue ($m), USD Constant, 2015-2025 230

Figure 78: Cytomegalovirus (CMV) Tests Market, Japan, Revenue ($m), USD Constant, 2015-2025 233

Figure 79: Hepatitis Tests Market, Japan, Revenue ($m), USD Constant, 2015-2025 235

Figure 80: Human Immunodeficiency Virus (HIV) Tests Market, Japan, Revenue ($m), USD Constant, 2015-2025 237

Figure 81: Human Papilloma Virus (HPV) Tests Market, Japan, Revenue ($m), USD Constant, 2015-2025 240

Figure 82: Human T-Lymphotropic Virus (HTLV) Tests Market, Japan, Revenue ($m), USD Constant, 2015-2025 242

Figure 83: Mycobacterium Tuberculosis Tests Market, Japan, Revenue ($m), USD Constant, 2015-2025 244

Figure 84: Neisseria Gonorrhoeae Tests Market, Japan, Revenue ($m), USD Constant, 2015-2025 246

Figure 85: Treponema pallidum Tests Market, Japan, Revenue ($m), USD Constant, 2015-2025 248

Figure 86: Infectious Disease Market, Japan, Volume (Units), 2015-2025 251

Figure 87: Chlamydia Trachomatis Tests Market, Japan, Volume (Units), 2015-2025 256

Figure 88: Clostridium difficile Tests Market, Japan, Volume (Units), 2015-2025 258

Figure 89: Cytomegalovirus (CMV) Tests Market, Japan, Volume (Units), 2015-2025 261

Figure 90: Hepatitis Tests Market, Japan, Volume (Units), 2015-2025 263

Figure 91: Human Immunodeficiency Virus (HIV) Tests Market, Japan, Volume (Units), 2015-2025 265

Figure 92: Human Papilloma Virus (HPV) Tests Market, Japan, Volume (Units), 2015-2025 268

Figure 93: Human T-Lymphotropic Virus (HTLV) Tests Market, Japan, Volume (Units), 2015-2025 270

Figure 94: Mycobacterium Tuberculosis Tests Market, Japan, Volume (Units), 2015-2025 272

Figure 95: Neisseria Gonorrhoeae Tests Market, Japan, Volume (Units), 2015-2025 274

Figure 96: Treponema pallidum Tests Market, Japan, Volume (Units), 2015-2025 276

Figure 97: Infectious Disease Market, Japan, Company Share (%) 2018 286

Figure 98: Infectious Disease Market, South Korea, Revenue ($m), USD Constant, 2015-2025 288

Figure 99: Chlamydia Trachomatis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 291

Figure 100: Clostridium difficile Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 293

Figure 101: Cytomegalovirus (CMV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 296

Figure 102: Hepatitis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 298

Figure 103: Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 300

Figure 104: Human Papilloma Virus (HPV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 303

Figure 105: Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 305

Figure 106: Mycobacterium Tuberculosis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 307

Figure 107: Neisseria Gonorrhoeae Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 309

Figure 108: Treponema pallidum Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 311

Figure 109: Infectious Disease Market, South Korea, Volume (Units), 2015-2025 314

Figure 110: Chlamydia Trachomatis Tests Market, South Korea, Volume (Units), 2015-2025 319

Figure 111: Clostridium difficile Tests Market, South Korea, Volume (Units), 2015-2025 321

Figure 112: Cytomegalovirus (CMV) Tests Market, South Korea, Volume (Units), 2015-2025 324

Figure 113: Hepatitis Tests Market, South Korea, Volume (Units), 2015-2025 326

Figure 114: Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Volume (Units), 2015-2025 328

Figure 115: Human Papilloma Virus (HPV) Tests Market, South Korea, Volume (Units), 2015-2025 331

Figure 116: Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Volume (Units), 2015-2025 333

Figure 117: Mycobacterium Tuberculosis Tests Market, South Korea, Volume (Units), 2015-2025 335

Figure 118: Neisseria Gonorrhoeae Tests Market, South Korea, Volume (Units), 2015-2025 337

Figure 119: Treponema pallidum Tests Market, South Korea, Volume (Units), 2015-2025 339

Figure 120: Infectious Disease Market, South Korea, Company Share (%) 2018 349

Frequently asked questions

Asia-Pacific Infectious Disease Market Outlook to 2025 standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Asia-Pacific Infectious Disease Market Outlook to 2025 in real time.

  • Access a live Asia-Pacific Infectious Disease Market Outlook to 2025 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more